VEGFA and colorectal carcinoma: A series of targeted drugs have been approved by the US Food and Drug Administration (FDA) for CRC treatment, including inhibitors of the epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF)-A, and VEGF-B6, 7.